Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis

다국어 초록 (Multilingual Abstract)

Bone marrow-derived mesenchymal stromal cells (MSCs) have been reported to be beneficial for the treatment of liver fibrosis. Here, we investigated the use of genetically engineered MSCs that overexpress hepatocyte growth factor (HGF) as a means to improve their therapeutic effect in liver fibrosis. Liver fibrosis was induced by intraperitoneal injection of dimethylnitrosamine. HGF-secreting MSCs (MSCs/HGF) were prepared by transducing MSCs with an adenovirus carrying HGF-encoding cDNA. MSCsor MSCs/HGF were injected directly into the spleen of fibrotic rats. Tissue fibrosis was assessed by histological analysis 12 days after stem cell injection. Although treatment with MSCs reduced fibrosis, treatment with MSCs/HGF produced a more significant reduction and was associated with elevated HGF levels in the portal vein. Collagen levels in the liver extract were decreased after MSC/HGF therapy, suggesting recovery from fibrosis. Furthermore, liver function was improved in animalsreceiving MSCs/HGF, indicating that MSC/HGF therapy resulted not only in reduction of liver fibrosis but also in improvement of hepatocyte function. Assessment of cell and biochemical parameters revealed that mRNA levels of the fibrogenic cytokines PDGF-bb and TGF-b1 were significantly decreased after MSC/HGF therapy. Subsequent to the decrease in collagen, expression of matrix metalloprotease-9 (MMP-9), MMP-13, MMP-14 and urokinase-type plasminogen activator was augmented following MSC/HGF, whereas tissue inhibitor of metalloprotease-1 (TIMP-1) expression was reduced. In conclusion, therapy with MSCs/HGF resulted in an improved therapeutic effect compared with MSCs alone, probably because of the anti-fibrotic activity of HGF. Thus, MSC/HGF represents a promising approach toward a cell therapy for liver fibrosis.

참고문헌 (Reference)

1 Sakaida I, "Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice" 40 : 1304-1311, 2004

2 Oyagi S, "Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats" 44 : 742-748, 2006

3 Russo FP, "The bone marrow functionally contributes to liver fibrosis" 130 : 1807-1821, 2006

4 Fang B, "Systemic infusion of FLK1(þ)mesenchymal stem cells ameliorate carbon tetrachlorideinduced liver fibrosis in mice" 78 : 83-88, 2004

5 Yamaura K, "Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation : induction of tolerance and prevention of cardiac allograft vasculopathy" 110 : 1650-1657, 2004

6 Okazaki I, "Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery" 50 : 58-65, 2001

7 Matsuda Y, "Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis" 26 : 81-89, 1997

8 Asawa S, "Participation of bone marrow cells in biliary fibrosis after bile duct ligation" 22 : 2001-2008, 2007

9 Grigorescu M, "Noninvasive biochemical markers of liver fibrosis" 15 : 149-159, 2006

10 Kim SS, "Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain" 26 : 2217-2228, 2008

11 Friedman SL, "Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury" 275 : 2247-2250, 2000

12 Edwards CA, "Modified assay for determination of hydroxyproline in a tissue hydrolyzate" 104 : 161-167, 1980

13 Bataller R, "Liver fibrosis" 115 : 209-218, 2005

14 Sotiropoulou PA, "Interactions between human mesenchymal stem cells and natural killer cells" 24 : 74-85, 2006

15 Ong SY, "Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture" 27 : 4087-4097, 2006

16 Lee KD, "In vitro hepatic differentiation of human mesenchymal stem cells" 40 : 1275-1284, 2004

17 Inoue S, "Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model" 81 : 1589-1595, 2006

18 Parekkadan B, "Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells" 363 : 247-252, 2007

19 Aggarwal S, "Human mesenchymal stem cells modulate allogeneic immune cell responses" 105 : 1815-1822, 2005

20 di Bonzo LV, "Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine : engraftment and hepatocyte differentiation versus profibrogenic potential" 57 : 223-231, 2008

21 Ishii T, "Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats" 117 : 1105-1112, 1995

22 Matsuno Y, "Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis" 10 : 1559-1566, 2003

23 Ueki T, "Hepatocyte growth factor gene therapy of liver cirrhosis in rats" 5 : 226-230, 1999

24 Ito W, "Hepatocyte growth factor attenuates airway hyperresponsiveness, inflammation, and remodeling" 32 : 268-280, 2005

25 Balkovetz DF, "Hepatocyte growth factor and Madin-Darby canine kidney cells : in vitro models of epithelial cell movement and morphogenesis" 43 : 456-463, 1998

26 Futamatsu H, "Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis : a potential role for induction of T helper 2cytokines" 96 : 823-830, 2005

27 Mizuno S, "Hepatocyte growth factor : a regenerative drug for acute hepatitis and liver cirrhosis" 2 : 161-170, 2007

28 Ong SY, "Hepatic differentiation potential of commercially available human mesenchymal stem cells" 12 : 3477-3485, 2006

29 Kim WH, "Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis" 166 : 1017-1028, 2005

30 Udenfriend S, "Formation of hydroxyproline in collagen" 152 : 1335-1340, 1966

31 Arthur MJ, "Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis" 279 : G245-G249, 2000

32 Tsukamoto H, "Experimental models of hepatic fibrosis : a review" 10 : 56-65, 1990

33 Madden JW, "Dimethylnitrosamine-induced hepatic cirrhosis: a new canine model of an ancient human disease" 68 : 260-267, 1970

34 Zhan Y, "Differentiation of hematopoietic stem cells into hepatocytes in liver fibrosis in rats" 38 : 3082-3085, 2006

35 Kallis YN, "Bone marrow stem cells and liver disease" 56 : 716-724, 2007

36 Carvalho AB, "Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury" 26 : 1307-1314, 2008

37 Yasuda H, "Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats" 24 : 636-642, 1996

38 Forbes SJ, "A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis" 126 : 955-963, 2004

39 Okunishi K, "A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function" 175 : 4745-4753, 2005